Tag: THRX

Major Movers on June 21; ZNGA, ORCL, KMX, DRI, THRX

Shares of Zynga Inc. (NASDAQ: ZNGA) plunged about 4.65% by afternoon trade. Morgan Stanley’s analyst Scott Devitt downgraded the social game maker’s stock to “underweight” from “overweight”. The research reports said that the popularity of its titles such as “FarmVille” “Poker” was fading fast as the competition was rising, adding that Zynga still relies far too heavily on Facebook Inc (NASDAQ: FB) to attract gamers. The research report said that company’s transition towards mobile gaming business will take some more time. Devitt thinks that Zynga might also slash more jobs in the futures, citing that it still employs more than required staff, which is weighing on EBITDA margin, the report added.

Continue reading Major Movers on June 21; ZNGA, ORCL, KMX, DRI, THRX

Major Movers on May 13; SCTY, CSIQ, PERI, THRX, PCYC, CITZ, YUM

Shares of SolarCity Corp. (NASDAQ: SCTY) soared about 30% by afternoon trade.  Shares of The San Mateo, California-based Company, which made its IPO back in December, have jumped almost four times so far. The Company is slated to report its quarterly results after the closing bell but investors are already excited about its future projects. Lately, the Company announced completion of two projects in Sacramento. The Company also said that installations of solar panels on about 6,500 homes in Marine and Navy bases in Hawaii are under way.

Continue reading Major Movers on May 13; SCTY, CSIQ, PERI, THRX, PCYC, CITZ, YUM

Major Movers on April 18; THRX, CLB, SNDK, EBAY, MS

Shares of Theravance Inc. (NASDAQ: THRX) rallied  about 15% by afternoon trade after a federal advisory panel on Wednesday said that proposed lung treatment drug, Breo Ellipta,  jointly developed by GlaxoSmithKline PLC and Theravance was not only effective but also safe and confirmed that it will approve the product . Breo Ellipta, which is meant to treat chronic obstructive pulmonary disease or COPD, is once-a-day inhalation drug.

Continue reading Major Movers on April 18; THRX, CLB, SNDK, EBAY, MS

Major Movers on April 15; THRX, ACOR, LIFE, TMO, NGD, ABX, GG, WLT, S

Shares of Theravance Inc. (NASDAQ: THRX) rallied on Monday after a report from the U.S. drug regulators showed that the once-a-day lung disease treatment Breo Ellipta, which the company is developing in conjunction with the GlaxoSmithKline Plc,  might get an approval.

Continue reading Major Movers on April 15; THRX, ACOR, LIFE, TMO, NGD, ABX, GG, WLT, S